NasdaqGS - Delayed Quote USD
Editas Medicine, Inc. (EDIT)
At close: November 4 at 4:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
499,153.0000
514,321.0000
677,483.0000
572,602.0000
Total Liabilities Net Minority Interest
150,056.0000
153,641.0000
123,841.0000
179,016.0000
Total Equity Gross Minority Interest
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Total Capitalization
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Common Stock Equity
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Capital Lease Obligations
36,536.0000
43,946.0000
26,378.0000
26,135.0000
Net Tangible Assets
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Working Capital
277,612.0000
296,644.0000
460,426.0000
360,879.0000
Invested Capital
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Tangible Book Value
349,097.0000
360,680.0000
553,642.0000
393,586.0000
Total Debt
36,536.0000
43,946.0000
26,378.0000
26,135.0000
Share Issued
81,767.2630
68,847.3820
68,435.2570
62,689.4570
Ordinary Shares Number
81,767.2630
68,847.3820
68,435.2570
62,563.4570
Treasury Shares Number
--
--
--
126.0000
12/31/2020 - 2/3/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTLA Intellia Therapeutics, Inc.
15.14
+2.23%
BEAM Beam Therapeutics Inc.
24.36
+6.24%
CRBU Caribou Biosciences, Inc.
2.3400
+5.88%
CRSP CRISPR Therapeutics AG
50.59
-0.33%
BLUE bluebird bio, Inc.
0.4630
-0.64%
VERV Verve Therapeutics, Inc.
6.05
+2.02%
SGMO Sangamo Therapeutics, Inc.
1.7400
-7.45%
FATE Fate Therapeutics, Inc.
2.7600
+13.58%
PRME Prime Medicine, Inc.
3.9600
-1.74%
ALLO Allogene Therapeutics, Inc.
3.0000
+10.29%